Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
orlistat cannabinoid receptor 1 NA Successful target TTD , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Body Weight[MeSHID:D001835]
Obesity[MeSHID:D009765]
Weight decreased[MeSHID:D015431]
Overweight[MeSHID:D050177]
Prescription procedure[MeSHID:D055656]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.16 approved unknown
orlistat fatty acid synthase small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Body Weight[MeSHID:D001835]
Obesity[MeSHID:D009765]
Weight decreased[MeSHID:D015431]
Overweight[MeSHID:D050177]
Prescription procedure[MeSHID:D055656]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.12 approved,investigational inhibitor
orlistat gastric triacylglycerol lipase small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Body Weight[MeSHID:D001835]
Obesity[MeSHID:D009765]
Weight decreased[MeSHID:D015431]
Overweight[MeSHID:D050177]
Prescription procedure[MeSHID:D055656]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 31.83 approved,investigational inhibitor
orlistat pancreatic triacylglycerol lipase small molecule Successful target TTD , drugbank , DGIDB Disease Management[MeSHID:D019468]
Maintenance[MeSHID:D008283]
Body Weight[MeSHID:D001835]
Obesity[MeSHID:D009765]
Weight decreased[MeSHID:D015431]
Overweight[MeSHID:D050177]
Prescription procedure[MeSHID:D055656]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 18.19 approved,investigational inhibitor
click here to return to the previous page